During the past decade, University of Calgary Liver Unit conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Calgary Liver Unit" #1 sponsor was "Mirum Pharmaceuticals, Inc." with 2 trials, followed by "Tobira Therapeutics, Inc." with 2 trials sponsored, "Axcella Health, Inc" with 1 trials sponsored, "Calliditas Therapeutics AB" with 1 trials sponsored and "CymaBay Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Calgary Liver Unit" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Calgary Liver Unit" are "Primary Biliary Cirrhosis" (2 trials), "Hepatitis C" (1 trials), "Hepatitis C, Chronic" (1 trials), "NASH - Nonalcoholic Steatohepatitis" (1 trials) and "Non Alcoholic Steatohepatitis (NASH)" (1 trials). Many other conditions were trialed in "University of Calgary Liver Unit" in a lesser frequency.

Most popular intervention types in "University of Calgary Liver Unit" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AXA1125" (1 trials), "Boceprevir" (1 trials), "Cenicriviroc" (1 trials) and "Cenicriviroc 150 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Calgary Liver Unit" are 11 trials for "All" genders.

Currently, there are NaN active trials in "University of Calgary Liver Unit". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University of Calgary Liver Unit, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Calgary Liver Unit, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".